Advertisement
ResearchIn-Press PreviewCell biologyOncology
Open Access | 10.1172/JCI183544
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Liu, K. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Zhang, Y. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Du, G. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Chen, X. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Xiao, L. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Jiang, L. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Jing, N. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Xu, P. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Zhao, C. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Liu, Y. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Zhao, H. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Sun, Y. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by
Wang, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Cheng, C. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Wang, D. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Pan, J. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Xue, W. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Zhang, P. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by
Zhang, Z.
in:
JCI
|
PubMed
|
Google Scholar
|
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Gao, W. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Jiang, S. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Zhang, K. in: JCI | PubMed | Google Scholar
1State Key Laboratory of Systems Medicine for Cancer, Renji-Med-X Stem Cell , Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2epartment of Emergency Medicine, Shanghai Seventh People’s Hospital, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China
3Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
4School of Biomedical Engineering, Shanghai Tech University, Shanghai, China
Find articles by Zhu, H. in: JCI | PubMed | Google Scholar
Published February 4, 2025 - More info
Serotonin (5-HT) is a neurotransmitter that has been linked to tumorigenesis. Whether and how 5-HT modulates cells in the microenvironment to regulate tumor metastasis remains to be largely unknown. Here, we demonstrate that 5-HT is secreted by neuroendocrine prostate cancer (NEPC) cells to communicate with neutrophils and to induce neutrophil extracellular traps (NETs) in the liver, which in turn facilitates the recruitment of disseminated cancer cells and promotes liver metastasis. 5-HT induces histone serotonylation (H3Q5ser) and orchestrates histone citrullination (H3cit) in neutrophils to trigger chromatin decondensation and facilitate the formation of NETs. Interestingly, we uncover in this process a reciprocally reinforcing effect between H3Q5ser and H3cit and a crosstalk between the respective writers TGM2 and PAD4. Genetic ablation or pharmacological targeting of TGM2, or inhibiting 5-HT transporter (SERT) with the FDA-approved antidepressant drug fluoxetine reduces H3Q5ser and H3cit modifications, suppresses NETs formation, and effectively inhibits NEPC, small cell lung cancer, and thyroid medullary cancer liver metastasis. Collectively, the 5-HT-triggered NETs production highlights a new targetable neurotransmitter-immune axis in driving liver metastasis of neuroendocrine cancers.